Last week Cancer Research UK made one of its regular forays to the European Parliament to launch a new report about the impact of the EU Clinical Trials Directive.
As you may know, the Directive is being reviewed by the EU institutions with a view to amendment, and the UK medical research lobby has been assertive in its view that the legislation in its current form is impeding research.
Cancer Research UK launched a report at its event which is not yet up on its website as far as I can see. But this coverage from the Daily Telegraph gives a good flavour of what was said. I was pleased to hear that one of Cancer Research UK’s patient ambassadors spoke at the meeting and, who knows, I might get them to blog their view here too.